Literature DB >> 9755742

Narcolepsy. Signs, symptoms, differential diagnosis, and management.

P M Green1, M J Stillman.   

Abstract

Narcolepsy is a chronic neurologic disorder characterized by excessive daytime sleepiness and cataplexy and less often by hypnagogic hallucinations and sleep paralysis. While patients report excessive daytime sleepiness and cataplexy as the more frequent symptoms of this condition, excessive daytime sleepiness is generally believed to be the most debilitating. Narcolepsy often is undiagnosed or misdiagnosed for a variety of reasons. Although confirmation of an initial diagnosis requires monitoring of physiologic variables conducted at a sleep center by specialists, the primary care physician has a critical role in the identification and management of this incurable affliction. This article provides recommendations for the diagnosis and management of narcolepsy. The cataplexy associated with narcolepsy can be managed with tricyclic antidepressants. The excessive sleepiness is managed with stimulants but newer agents, such as modafinil, which will be marketed as Provigil, and selegiline hydrochloride, with fewer adverse effects and less abuse potential, may offer means of promoting daytime wakefulness. Groups such as the National Sleep Foundation, Washington, DC, and the Narcolepsy Network, Cincinnati, Ohio, can provide patients with needed support and information.

Entities:  

Mesh:

Year:  1998        PMID: 9755742     DOI: 10.1001/archfami.7.5.472

Source DB:  PubMed          Journal:  Arch Fam Med        ISSN: 1063-3987


  3 in total

1.  Primary Care: Is It the Setting to Address Sleep Disorders?

Authors:  William C. Dement; Nikolaus C. Netzer
Journal:  Sleep Breath       Date:  2000       Impact factor: 2.816

2.  The long-term tolerability and efficacy of armodafinil in patients with excessive sleepiness associated with treated obstructive sleep apnea, shift work disorder, or narcolepsy: an open-label extension study.

Authors:  Jed E Black; Steven G Hull; Jane Tiller; Ronghua Yang; John R Harsh
Journal:  J Clin Sleep Med       Date:  2010-10-15       Impact factor: 4.062

3.  Behavioral effects of modafinil in marmoset monkeys.

Authors:  Sanneke A M van Vliet; Marjan J Jongsma; Raymond A P Vanwersch; Berend Olivier; Ingrid H C H M Philippens
Journal:  Psychopharmacology (Berl)       Date:  2006-03-21       Impact factor: 4.415

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.